Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$250,381
+$31,369 QoQ
Shares Held
995
-1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#3,780
of 4,153 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIDUCIARY FINANCIAL GROUP, LLC holds $7,036,128 across 10 Drug Manufacturers - General names. ABBV ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,469 | $1,761,962 | |
| 2 | JNJ |
Johnson & Johnson
|
5,744 | $1,458,803 | |
| 3 | AMGN |
Amgen Inc
|
2,525 | $914,353 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,015 | $772,927 | |
| 5 | NVS |
Novartis AG
|
3,929 | $615,752 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,846 | $452,086 | |
| 7 | SNY |
Sanofi
|
8,403 | $358,471 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
995 | $250,381 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,381 | 995 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $219,012 | 1,007 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $390,839 | 1,688 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $280,657 | 1,512 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $346,127 | 1,652 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $296,403 | 1,668 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $289,703 | 1,467 | Shares | Sole | 2024-10-10 | |
| No filing history on record for this holder in this stock. | ||||||